Autoimmunity and Autoinflammatory Genetic Syndromes

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: closed (25 March 2024) | Viewed by 3862

Special Issue Editor


E-Mail Website
Guest Editor
Istituto di Medicina Genomica, Università Cattolica del Sacro Cuore, Rome, Italy
Interests: mouse genetics; embryological development; molecular bases of cancer; genetics of familial kidney diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

The scope of this Special Issue is to highlight the unique role of autoimmune or autoinflammatory phenotypes with a hereditary inheritance, in uncovering the role of different pathways in the pathogenesis of these disorders.

Autoimmunity and autoinflammatory diseases are conditions involving different aspects of the immune system. While autoimmunity involves the adaptive response, mediated by B and T lymphocytes and autoantibodies, autoinflammatory diseases are caused by the dysregulation of natural immunity, through the inflammasome, with all its players. However, this classical definition is challenged by conditions like Behcet’s syndrome, where the involvement of both arms of the immune system is present. The complexity of all those conditions is increased by the close relationship of the immune system with the environment. In all autoimmune and autoinflammatory disorders, environmental triggers give an important contribution along with genetic factors, suggesting that a complex architecture is responsible for the final phenotype. Most of the common autoimmune diseases, such as Systemic Lupus Erythematous, Rheumatoid Arthritis, Multiple Sclerosis, and Sjogren’s syndrome, usually do not show a classical Mendelian inheritance. In these cases, given the probable complex multifactorial origin, genome-wide association studies (GWAS) have been applied to uncover common gene variants responsible for the increased risk. However, the genetic variants discovered by GWAS contributed to a small fraction of the overall risk and many times was not possible to identify the mechanism of a variant in determining the pathogenesis of the disease. On the other side, for many autoinflammatory conditions, such as Familial Mediterranean Fever, Cryopyrinopathies, and TRAPS, there is a major gene responsible for the disease, and it is possible to confirm the clinical diagnosis with a molecular test. However, even for autoinflammatory disorders 70-80% of the cases do not show a Mendelian inheritance, and they are sometimes defined as SURF (Syndrome of Undifferentiated Recurrent Fever), indicating that those patients have a clinical diagnosis of autoinflammatory disease, characterized just by recurrent fever, but the underlying cause or mechanism is still unknown.

In approximately 5 to 10% of all autoimmune/autoinflammatory disorders, it is possible to suspect monogenic or familial segregation of the disease, more often dominant or in some cases recessive, suggesting that a major variant in a gene represents a strong predisposing factor for the development of the disease. In these cases, the new technologies of sequencing, exome and whole genome sequencing, along with classical linkage analysis, allowed the identification of new genes making it possible to further extend our knowledge.

The discovery of genes responsible for monogenic forms of common diseases already helped to have better diagnoses, supported by a molecular mechanism and it will help to identify new molecular targets for newer and more effective treatments.

Dr. Eugenio Sangiorgi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

11 pages, 511 KiB  
Article
Predictive Clinical and Biological Criteria for Gene Panel Positivity in Suspected Inherited Autoinflammatory Diseases: Insights from a Case–Control Study
by Lionel Heiser, Martin Broly, Cécile Rittore, Isabelle Touitou, Sophie Georgin-Lavialle and Guilaine Boursier
Genes 2023, 14(10), 1939; https://doi.org/10.3390/genes14101939 - 14 Oct 2023
Cited by 2 | Viewed by 877
Abstract
In order to assess the clinical and biological criteria that predict gene panel positivity in patients with a suspected inherited genetic autoinflammatory disease, we conducted a case–control study. These new selection criteria could replace the national multidisciplinary staff approval before performing genetic testing [...] Read more.
In order to assess the clinical and biological criteria that predict gene panel positivity in patients with a suspected inherited genetic autoinflammatory disease, we conducted a case–control study. These new selection criteria could replace the national multidisciplinary staff approval before performing genetic testing that has been required since 2019. The study involved 119 positive gene panels matched by panel sizes to 119 randomly selected negative gene panels. The patients were referred to our laboratory for genetic testing between June 2012, and March 2023. The clinical and biological criteria were extracted from a prospectively filled database. We focused our evaluation on accuracy and the positive predictive value. Neonatal symptom onset and deafness had the highest accuracies among all criteria associated with the positivity panel, with 92.9% (88.6; 96.0) and 92.6% (88.5; 95.6), respectively. However, it is important to note that the associated Positive Predictive Values (PPVs) cannot exceed 50%. Despite finding a statistical association between clinical and biological criteria and panel positivity, the predictive values of these criteria were not sufficient to recommend Next-Generation Sequencing (NGS) gene panel testing without the national multidisciplinary staff evaluation. Full article
(This article belongs to the Special Issue Autoimmunity and Autoinflammatory Genetic Syndromes)
Show Figures

Graphical abstract

9 pages, 624 KiB  
Article
Identification by Exome Sequencing of Predisposing Variants in Familial Cases of Autoinflammatory Recurrent Fevers
by Eugenio Sangiorgi, Alessia Azzarà, Roberto Rumore, Ilaria Cassano, Elena Verrecchia, Luciano Giacò, Maria Alessandra Tullio, Fiorella Gurrieri and Raffaele Manna
Genes 2023, 14(7), 1310; https://doi.org/10.3390/genes14071310 - 21 Jun 2023
Viewed by 1030
Abstract
Periodic fever syndromes include autoinflammatory disorders (AID) that involve innate immunity. These disorders are characterized by recurrent fevers and aberrant multi-organ inflammation, without any involvement of T or B cells or the presence of autoantibodies. A complex genetic architecture has been recognized for [...] Read more.
Periodic fever syndromes include autoinflammatory disorders (AID) that involve innate immunity. These disorders are characterized by recurrent fevers and aberrant multi-organ inflammation, without any involvement of T or B cells or the presence of autoantibodies. A complex genetic architecture has been recognized for many AID. However, this complexity has only been partially uncovered for familial Mediterranean fever and other conditions that have a classical monogenic origin and Mendelian transmission. Several gene panels are currently available for molecular diagnosis in patients suspected of having AID. However, even when an extensive number of genes (up to 50–100) are tested in a cohort of clinically selected patients, the diagnostic yield of AID ranges between 15% and 25%, depending on the clinical criteria used for patient selection. In the remaining 75–85% of cases, it is conceivable that the causative gene or genes responsible for a specific condition are still elusive. In these cases, the disease could be explained by variants, either recessive or dominant, that have a major effect on unknown genes, or by the cumulative impact of different variants in more than one gene, each with minor additive effects. In this study, we focused our attention on five familial cases of AID presenting with classical autosomal dominant transmission. To identify the probable monogenic cause, we performed exome sequencing. Through prioritization, filtering, and segregation analysis, we identified a few variants for each family. Subsequent bioinformatics evaluation and pathway analysis helped to narrow down the best candidate genes for each family to FCRL6, PKN1, STAB1, PTDGR, and VCAM1. Future studies on larger cohorts of familial cases will help confirm the pathogenic role of these genes in the pathogenesis of these complex disorders. Full article
(This article belongs to the Special Issue Autoimmunity and Autoinflammatory Genetic Syndromes)
Show Figures

Figure 1

Other

Jump to: Research

16 pages, 1765 KiB  
Systematic Review
PSTPIP1-Associated Myeloid-Related Proteinemia Inflammatory (PAMI) Syndrome: A Systematic Review
by Manel Mejbri, Raffaele Renella, Fabio Candotti, Cecile Jaques, Dirk Holzinger, Michael Hofer and Katerina Theodoropoulou
Genes 2023, 14(8), 1655; https://doi.org/10.3390/genes14081655 - 19 Aug 2023
Viewed by 1502
Abstract
PSTPIP1 (proline-serine-threonine phosphatase-interactive protein 1)-associated myeloid-related proteinemia inflammatory (PAMI) syndrome, previously known as Hyperzincemia/Hypercalprotectinemia (Hz/Hc) syndrome, is a recently described, rare auto-inflammatory disorder caused by specific deleterious variants in the PSTPIP1 gene (p.E250K and p.E257K). The disease is characterized by chronic systemic inflammation, [...] Read more.
PSTPIP1 (proline-serine-threonine phosphatase-interactive protein 1)-associated myeloid-related proteinemia inflammatory (PAMI) syndrome, previously known as Hyperzincemia/Hypercalprotectinemia (Hz/Hc) syndrome, is a recently described, rare auto-inflammatory disorder caused by specific deleterious variants in the PSTPIP1 gene (p.E250K and p.E257K). The disease is characterized by chronic systemic inflammation, cutaneous and osteoarticular manifestations, hepatosplenomegaly, anemia, and neutropenia. Increased blood levels of MRP 8/14 and zinc distinguish this condition from other PSTPIP1-associated inflammatory diseases (PAID). The aim of this systematic review is to provide a comprehensive overview of the disease phenotype, course, treatment, and outcome based on reported cases. This systematic review adheres to the PRISMA guidelines (2020) for reporting. A literature search was performed in Embase, Medline, and Web of Science on 13 October 2022. The quality of the case reports and case series was assessed using the JBI checklists. Out of the 43 included patients with PAMI syndrome, there were 24 females and 19 males. The median age at onset was 3.9 years. The main clinical manifestations included anemia (100%), neutropenia (98%), cutaneous manifestations (74%), osteoarticular manifestations (72%), splenomegaly (70%), growth failure (57%), fever (51%), hepatomegaly (56%), and lymphadenopathy (39%). Systemic inflammation was described in all patients. Marked elevation of zinc and MRP 8/14 blood levels were observed in all tested patients. Response to treatment varied and no consistently effective therapy was identified. The most common therapeutic options were corticosteroids (N = 30), anakinra (N = 13), cyclosporine A (N = 11), canakinumab (N = 6), and anti-TNF (N = 14). Hematopoietic stem cell transplantation has been recently reported to be successful in five patients. Our review highlights the key characteristics of PAMI syndrome and the importance of considering this disease in the differential diagnosis of patients presenting with early-onset systemic inflammation and cytopenia. Full article
(This article belongs to the Special Issue Autoimmunity and Autoinflammatory Genetic Syndromes)
Show Figures

Figure 1

Back to TopTop